360 Participants Needed

Integrative Pain Management for Chronic Pain

(IPMP+ Trial)

JW
Overseen ByJulia Wu, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore new ways to manage chronic pain in low-income, racially, and ethnically diverse individuals. Researchers are testing two main treatments: group acupuncture, which uses needles to stimulate specific points on the body, and integrative group medical visits that include education on pain, physical movement, mindfulness training, and peer support. The goal is to find more effective, non-drug methods to help those who feel isolated and face challenges in pain care. Individuals with chronic pain for more than three months, who have recently seen a primary care doctor for their pain, and can join group sessions might be a good fit for this study. As an unphased trial, this study offers a unique opportunity to contribute to innovative pain management solutions.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both group acupuncture and integrative group medical visits (IGMV) are generally well-tolerated by patients. Group acupuncture effectively reduces pain and improves physical function without serious side effects. Patients often feel relaxed after treatments, and side effects, such as minor bruising, are rare.

IGMV combines education and support with various non-drug therapies. Participants learn to manage pain through lifestyle changes and receive support from others with similar experiences. Studies suggest this method is safe and helps improve pain management without significant negative effects.

Overall, both treatments have shown promise in improving pain and are considered safe based on past research.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments for chronic pain because they incorporate holistic approaches that go beyond typical pain management strategies like medication and physical therapy. Group Acupuncture offers tailored acupuncture sessions in a community setting, which may enhance both physical and emotional well-being through social support and traditional Chinese medicine techniques. Integrative Group Medical Visits (IGMV) take a comprehensive approach by combining education on pain management, mindfulness, and peer support, all within a structured 12-week program. This combination not only addresses physical symptoms but also targets mental and social aspects of chronic pain, aiming to provide a more rounded and sustainable relief option compared to standard care.

What evidence suggests that this trial's treatments could be effective for chronic pain?

Research has shown that integrative group medical visits (IGMV), one of the treatments in this trial, can help manage chronic pain. One study found that these visits reduced the need for pain medication and improved overall well-being. Participants in IGMV reported better physical and mental health, experiencing less pain and improved social interactions.

For group acupuncture, another treatment option in this trial, studies indicate it can greatly reduce pain and enhance physical abilities. After three months of group acupuncture, about 30% of participants reported a significant decrease in how much pain affected their daily lives. Both treatments offer promising options for managing chronic pain, and this trial will evaluate their effectiveness.13567

Who Is on the Research Team?

MC

Maria Chao, DrPH, MPA

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for individuals from low-income backgrounds who are experiencing chronic pain and receive care at primary safety net clinics. It aims to help those affected by social isolation, stigma, and disparities in pain management.

Inclusion Criteria

Intent to be available for up to 24 weeks
I can provide a contact phone number.
I visited my doctor for chronic pain in the last 6 months.
See 3 more

Exclusion Criteria

I have participated in a group pain management program recently.
I am able to understand and consent to my medical treatment.
I have had acupuncture for pain within the last 3 months.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Integrative Group Medical Visits (IGMV), group acupuncture, both, or usual care for 12 weeks

12 weeks
Weekly group sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks
2 visits (in-person)

Final Follow-up

Final assessment of outcomes including pain impact and social support

6 months after baseline

What Are the Treatments Tested in This Trial?

Interventions

  • Group Acupuncture
  • Integrative Group Medical Visits
Trial Overview The study is testing two group-based treatments: acupuncture and integrative group medical visits. These approaches are designed to address chronic pain using a comprehensive model that considers biological, psychological, and social factors.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Integrative Group Medical Visits (IGMV)Experimental Treatment1 Intervention
Group II: Group Acupuncture and IGMVExperimental Treatment2 Interventions
Group III: Group AcupunctureExperimental Treatment1 Intervention
Group IV: Usual CareActive Control1 Intervention

Group Acupuncture is already approved in United States, European Union, China, Canada for the following indications:

🇺🇸
Approved in United States as Acupuncture for:
🇪🇺
Approved in European Union as Acupuncture Therapy for:
🇨🇳
Approved in China as Traditional Chinese Medicine Acupuncture for:
🇨🇦
Approved in Canada as Acupuncture Treatment for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

A retrospective study of 218 chronic pain patients showed that a comprehensive interdisciplinary pain management program led to significant improvements in physical and mental health, with 77% of participants reporting substantial improvement immediately after the program and 76% at 12 months post-discharge.
The program also positively impacted social health outcomes, with notable increases in employment and educational levels among participants, particularly those previously on disability or part-time work.
Long term outcomes of chronic pain patients attending a publicly funded community-based interdisciplinary pain program in the Greater Toronto area: results of a practice-based audit.Mailis, A., Deshpande, A., Lakha, SF.[2022]
Interdisciplinary chronic pain management programs, which incorporate the biopsychosocial model of pain, have been shown to be more therapeutically effective and cost-effective compared to traditional medical interventions.
Despite their effectiveness, there are significant barriers to the wider implementation of these interdisciplinary programs, highlighting the need for future efforts to promote their use in chronic pain treatment.
Interdisciplinary chronic pain management: past, present, and future.Gatchel, RJ., McGeary, DD., McGeary, CA., et al.[2022]
A pilot study involving 19 Spanish-speaking Latino patients with chronic pain demonstrated that an adapted Integrative Medical Group Visit (IMGV) curriculum significantly reduced pain interference, fatigue, and depression, indicating its efficacy as a nonpharmacological treatment option.
Participants reported positive experiences and benefits from the program, highlighting the importance of providing care in Spanish, which may help address healthcare disparities in this underserved population.
The Latino Integrative Medical Group Visit as a Model for Pain Reduction in Underserved Spanish Speakers.Cornelio-Flores, O., Lestoquoy, AS., Abdallah, S., et al.[2022]

Citations

Acupuncture Therapy in a Group Setting for Chronic PainAcupuncture therapy offered in the group setting was effective in reducing pain severity, pain interference, and depression in patients with chronic neck, back ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/32076985/
Individual vs. Group Delivery of Acupuncture Therapy for ...Key results: 37.5% of individual arm and 30.3% in group had > 30% improvement in pain interference (d = 7.2%, 95% CI - 0.6%, 15.1%). Non- ...
Individual vs. Group Delivery of Acupuncture Therapy for ...Both individual and group acupuncture therapy delivered in primary care settings reduced chronic pain and improved physical function at 12 weeks.
Comparing Group and Individual Acupuncture Therapy for ...Three months after treatment ended, 30 percent of patients who had group acupuncture sessions reported large decreases in how much pain disrupted their daily ...
Acupuncture for Chronic Pain: Individual Patient Data Meta ...We aimed to determine the effect size of acupuncture for 4 chronic pain conditions: back and neck pain, osteoarthritis, chronic headache, and shoulder pain.
Group-based Integrative Pain Management in Primary ...The investigators will test the hypotheses that compared with usual care, group acupuncture and IGMV improve pain outcomes among racially and ethnically diverse ...
Group-Based Integrative Pain Management: Feasibility of a ...This study tests the hypotheses that assignment to group acupuncture or IGMV will improve pain outcomes and social support in participants with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security